BAX and early-onset autosomal dominant Alzheimer disease: TDNs can inhibit the level of reactive oxygen species in the Alzheimer's disease model, thereby inhibiting the expression of Bax, attenuating the activation of Caspase, inhibiting the apoptosis‐related signalling pathway and finally inhibiting apoptosis.